Jeil Pharmaceutical Co. Ltd. | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW1199.35 |
Market Cap |
KRW334.66 B |
Shares Outstanding |
15.97 M |
Public Float |
2.19 M |
Address |
343 Sapyeong-daero Seoul SL 06543 Korea, Republic Of |
Employees | - |
Website | - |
Updated | 07/08/2019 |
Jeil Pharma Holdings, Inc. engages in the manufacture and sale of pharmaceutical products. Its products include active pharmaceutical ingredients and finished dosage forms. The active pharmaceutical ingredients provide medicines for antibiotic, oncology, cardiovascular, gastrointestinal, neuropsychiatry, urology, endocrinology, respiratory, antiviral, and musculoskeletal. |